RE:RE:RE:RE:RE:RE:RE:Conditions are right for biopharma M&A to break outI hold the same views as capitalista and Fox7mf. We await a business deal of substance which could range from a buyout, to a partnership, to funding for two p 3 trials, from best to least impact.